As of May 18
| 0.00 / 0.00%|
The 10 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 20.50, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a -16.84% decrease from the last price of 24.65.
The current consensus among 11 polled investment analysts is to Hold stock in AMAG Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.